Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
38,432,409
-
Share change
-
+20,963
-
Total reported value
-
$5,277,616,107
-
Put/Call ratio
-
423%
-
Price per share
-
$137.26
-
Number of holders
-
886
-
Value change
-
+$719,237
-
Number of buys
-
262
-
Number of sells
-
393
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2024
As of 30 Jun 2024 ISHARES TR - ISHARES BIOTECH (IBB) had 886 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,432,409 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, CITIGROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, BNP PARIBAS FINANCIAL MARKETS, Royal Bank of Canada, JANE STREET GROUP, LLC, UBS Group AG, and COMMERCE BANK.
This table shows 888 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.